三博脑科(301293.SZ)：目前公司神经调控技术带来的收入占公司营业收入比重很小

Core Viewpoint - Sanbo Neuroscience (301293.SZ) is a medical service group specializing in neurology, primarily providing advanced neurosurgical services, with current revenue from neuromodulation technology being minimal and not significantly impacting overall performance [1] Company Overview - The company operates as a specialized medical service group focused on neurology [1] - Its main facilities offer comprehensive medical services centered around high-end neurosurgery [1] Revenue Insights - Revenue generated from neuromodulation technology constitutes a small portion of the company's total revenue [1] - The impact of this revenue stream on the company's overall performance is negligible [1]